Sign Out
Pregnancy: Fusidic acid: No effects during pregnancy are anticipated, since systemic exposure to fusidic acid is negligible and studies in animals have not shown teratogenic effects.
Betamethasone valerate: There are no or limited amount of data from the use of topical betamethasone valerate in pregnant women. Studies in animals have shown reproductive toxicity (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Fucicort should not be used during pregnancy unless clearly necessary.
Breastfeeding: No effects on the breastfed newborn/infant are anticipated since the systemic exposure of topically applied fusidic acid and betamethasone valerate to a limited area of skin of the breastfeeding woman is negligible.
Fucicort can be used during breastfeeding but it is recommended to avoid applying Fucicort on the breast.
Fertility: There are no clinical studies with Fucicort regarding fertility.
